osteoarthritis of the hip, osteonecrosis of the femoral head (Ficat IIIB or IV), and developmental dysplasia of the hip.
Conditions
Interventions
Experimental group:pericapsular nerve group (PENG) block combined with infiltration between piriformis and capsule of hip (IPCH)
Sponsors
Department of Anesthesiology, West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 80 years; 2. Body mass index (BMI) of 20-35 kg/m2; 3. The functional status of American Society of Anesthesiologists (ASA) I-III; 4. Primary unilateral total hip replacement.
Exclusion criteria
Exclusion criteria: 1. Ankylosis of the hip joint; 2. Known allergy to the drugs used in this study; 3. History of opioid overdose; 4. There is a history of excessive drinking; 5. Cognitive impairment; 6. Mental illness; 7. Recognized neuromuscular disease; 8. History of previous hip open surgery; 9. The target hip has other neurological diseases; 10. Inability to communicate verbally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dosage of morphine within 24 h after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative consumption of opioids;Postoperative Visual Analogue Scale Score at rest;Postoperative Visual Analogue Scale Score at motion;Times of sleep interruption due to pain on the night of surgery;Postoperative quadriceps strength;Time until the first walkout of bed after surgery;Time to hospital discharge;postoperative adverse events;Total morphine consumption during hospitalization; | — |
Countries
China
Contacts
Public ContactYang Jing
West China Hospital, Sichuan University
Outcome results
None listed